Enhancement of tumor-specific immune response with plasmid DNA replicon vectors

Cancer Research

Volumn 60, Issue 1, 2000, Pages 51-55

  Leitner, Wolfgang W ^a   Ying, Han ^a   Driver, David A ^b   Dubensky, Thomas W ^b   Restifo, Nicholas P ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; NUCLEIC ACID;

ANIMAL EXPERIMENT; ARTICLE; DRUG POTENTIATION; DRUG SAFETY; EXPRESSION VECTOR; FEMALE; IMMUNOGENICITY; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPLICON; VACCINE PRODUCTION;

ANIMALS; ANTIGENS, NEOPLASM; APOPTOSIS; CANCER VACCINES; CYTOMEGALOVIRUS; FEMALE; GENETIC VECTORS; LAC OPERON; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; REPLICON; TRANSFECTION; VACCINES, DNA;

EID: 0033955167     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Hellstrom, I., and Hellstrom, K. E. Tumor vaccines-a reality at last? J. Immunother., 21: 119-126, 1998.
2. Minev, B. R., Chavez, F. L., and Mitchell, M. S. Cancer vaccines: novel approaches and new promise. Pharmacol. Ther., 81: 121-139, 1999.
3. Pardoll, D. M., and Beckerleg, A. M. Exposing the immunology of naked DNA vaccines. Immunity, 3: 165-169, 1995.
4. Irvine, K. R., Rao, J. B., Rosenberg, S. A., and Restifo, N. P. Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases. J. Immunol., 156: 238-245, 1996.
5. Gurunathan, S., Irvine, K. R., Wu, C. Y., Cohen, J. I., Thomas, E., Prussin, C., Restifo, N. P., and Seder, R. A. CD40 ligand/trimer DNA enhances both humoral and cellular immune responses and induces protective immunity to infectious and tumor challenge. J. Immunol., 161: 4563-4571, 1998.
6. Lee, S. S., Eisenlohr, L. C., McCue, P. A., Mastrangelo, M. J., and Lattime, E. C. Intravesical gene therapy: in vivo gene transfer using recombinant vaccinia virus vectors. Cancer Res., 54: 3325-3328, 1994.
7. Donnelly, J. J., Ulmer, J. B., Shiver, J. W., and Liu, M. A. DNA vaccines. Annu. Rev. Immunol., 15: 617-648, 1997.
8. Dubensky, T. W. J., Driver, D. A., Polo, J. M., Belli, B. A., Latham, E. M., Ibanez, C. E., Chada, S., Brumm, D., Banks, T. A., Mento, S. J., Jolly, D. J., and Chang, S. M. Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer. J. Virol., 70: 508-519. 1996.
9. Driver, D. A., Polo, J. M., Belli, B. A., Banks, T. A., Hariharan, M. J., and Dubensky, T. W. Plasmid DNA-based alphavirus expression vectors for nucleic acid immunization. Curr. Res. Mol. Therapeut., 1: 510-517, 1998.
10. Hariharan, M. J., Driver, D. A., Townsend, K., Brumm, D., Polo, J. M., Belli, B. A., Catton, D. J., Hsu, D., Mittelstaedt, D., McCormack, J. E., Karavodin, L., Dubensky, T. W. J., Chang, S. M., and Banks, T. A. DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector. J. Virol., 72: 950-958, 1998.
11. Berglund, P., Smerdou, C., Fleeton, M. N., Tubulekas, I., and Liljestrom, P. Enhancing immune responses using suicidal DNA vaccines. Nat. Biotechnol., 16: 562-565, 1998.
12. Schlesinger, S., and Dubensky, T. W. Alphavirus vectors for gene expression and vaccines. Curr. Opin. Biotechnol., 10: 434-439, 1999.
13. Ying, H., Zaks, T. Z., Wang, R. F., Irvine, K. R., Kammula, U. S., Marincola, F. M., Leitner, W. W., and Restifo, N. P. Cancer therapy using a self-replicating RNA vaccine. Nat. Med., 5: 823-827, 1999.
14. Wang, M., Bronte, V., Chen, P. W., Gritz, L., Panicali, D., Rosenberg, S. A., and Restifo, N. P. Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen. J. Immunol., 154: 4685-4692, 1995.
15. Bronte, V., Carroll, M. W., Goletz, T. J., Wang, M., Overwijk, W. W., Marincola, F., Rosenberg, S. A., Moss, B., and Restifo, N. P. Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine. Proc. Natl. Acad. Sci. USA. 94: 3183-3188, 1997
16. Glasgow, G. M., McGee, M. M., Tarbatt, C. J., Mooney, D. A., Sheahan, B. J., and Atkins, G. J. The Semliki Forest virus vector induces p53-independent apoptosis. J. Gen. Virol., 79: 2405-2410, 1998.
17. Nava, V. E., Rosen, A., Veliuona, M. A., Clem, R. J., Levine, B., and Hardwick, J. M. Sindbis virus induces apoptosis through a caspase-dependent, CrmA-sensitive pathway. J. Virol., 72: 452-459, 1998.
18. Tanaka, N., Sato, M., Lamphier, M. S., Nozawa, H., Oda, E., Noguchi, S., Schreiber, R. D., Tsujitnoto, Y., and Taniguchi, T. Type I interferons are essential mediators of apoptotic death in virally infected cells. Genes Cells, 3: 29-37, 1998.
19. Diaz-Guerra, M., Rivas, C., and Esteban, M. Activation of the IFN-inducible enzyme RNase L causes apoptosis of animal cells. Virology, 236: 354-363, 1997.
20. Der, S. D., Yang, Y. L., Weissmann, C., and Williams, B. R. A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis, Proc. Natl. Acad. Sci. USA. 94: 3279-3283, 1997.
21. Albert, M. L., Sauter, B., and Bhardwaj, N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature (Lond.), 392: 86-89, 1998.
22. Albert, M. L., Pearce, S. A., Francisco, L. M., Sauter, B., Roy, P., Silverstein, R. L., and Bhardwaj, N. Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med., 188: 1359-1368, 1998.
23. Cella, M., Salio, M., Sakakibara, Y., Langen, H., Julkunen, I., and Lanzavecchia, A. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med., 189, 821-829, 1999.
24. Leitner, W. W., Ying, H., and Restifo, N. P. DNA and RNA-based vaccines: principles, progress and prospects. Vaccine, 18: 765-777, 1999.